NoyMed
NoyMed is a privately held niche biometrics CRO with full clinical operations capabilities, providing Phase I-IV biostatistics, SAS/CDISC programming, data management, medical writing, and pharmacovigilance services to pharmaceutical, biotechnology, medical device companies and research institutes globally.
- Company typePrivate
- Founded2017
- HeadquartersGlendale, United States
- Headcount101–250
- GTM typeB2B
- OfferingServices
What NoyMed does
NoyMed is a privately held Contract Research Organization (CRO) founded in 2017 with headquarters in Glendale, California and execution offices in Yerevan and Vanadzor, Armenia. The company positions itself as a niche biometrics CRO with full clinical operations (ClinOps) capabilities, supporting Phase I-IV clinical trials for pharmaceutical, biotechnology, medical device companies, and research institutes globally. Its service portfolio spans Biostatistics with PK/PD analysis, Statistical Programming (SAS) with CDISC conversion (SDTM/ADaM, CDASH, Define.xml), end-to-end Data Management, Clinical Operations, Medical Writing, and Pharmacovigilance.
Underlying technology centers on SAS programming with CDISC regulatory standards and a partner relationship with the TrialKit EDC platform, which the company describes as supporting over 8,000 studies globally with web, mobile, and wearable-based remote data capture. NoyMed also claims an adaptive clinical trial design methodology delivering a 25-35% efficiency uplift and a 2-week turnaround from database lock to data analysis and review (4 weeks faster than industry average).
NoyMed operates a project-based professional services revenue model with custom quote-based pricing and multi-year contracts. Go-to-market is enterprise direct sales targeting pharmaceutical, biotechnology, medical device, and research institute buyers, executed through the website's "Request a Quote" flow and direct email. Distribution leverages multi-timezone coverage across US and Armenia offices. The company is owned by three co-founders — Armen Margaryan (CEO), Ani Markosyan (CSO), and Tatevik Simonyan — with no disclosed external institutional investors or funding rounds. Therapeutic-area exposure spans oncology (16.5% of recent mix), neurology/CNS, cardiovascular, dermatology, metabolic disease, anti-infective, ophthalmology, allergy/respiratory, gastroenterology, anti-inflammatory, vaccine, and immunology. (Note: firmographic data lists a 2012 founding year, while the company-history timeline records 2017 — 2017 is used as the more specific reference.)
NoyMed firmographics
Firmographics- Name
- NoyMed
- Legal name
- NoyMed
- Website
- https://noymed.com
- Company type
- Private
- Founded year
- 2017
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- NoyMed is a privately held niche biometrics CRO with full clinical operations capabilities, providing Phase I-IV biostatistics, SAS/CDISC programming, data management, medical writing, and pharmacovigilance services to pharmaceutical, biotechnology, medical device companies and research institutes globally.
- Ownership category
- akta.pro rank
NoyMed industry classification
Industry- Product category
- Contract Research Organization (CRO) Services
- NAICS
- Scientific Research and Development Services (5417)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Clinical Data Management, Biostatistics & Statistical Programming CROs (HLAGAAAF)
- akta.pro secondary industry
- Central Laboratory & Clinical Trial Testing CROs (HLAGAAAE)
Keywords
Where NoyMed is headquartered
LocationHeadquarters
- HQ city
- Glendale
- HQ country
- United States
- HQ region
- North America
Offices3 records
Markets served
NoyMed business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales
Revenue model
- Clinical Research Services: Full-service CRO providing end-to-end clinical trial solutions including biometrics, clinical operations, pharmacovigilance, and medical writing services to pharmaceutical, biotech, and medical device companies. Revenue generated through project-based contracts and service agreements.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Custom project-based pricing |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels4 records
NoyMed product offering
Product offeringCore offering
NoyMed is a Contract Research Organization (CRO) providing biometrics and clinical operations services to pharmaceutical, biotechnology, and medical device companies. Its services include biostatistics and PK/PD analysis, SAS statistical programming with CDISC-compliant datasets, full data management on the TrialKit EDC platform, end-to-end clinical trial operations, medical writing, and pharmacovigilance.
Product overview
NoyMed is a niche Biometrics CRO providing a comprehensive suite of clinical trial services alongside its proprietary TrialKit EDC platform. The service portfolio includes Biostatistics-PK/PD Analysis, Statistical Programming (SAS/CDISC), Full Data Management, End to End Clinical Operations, Medical Writing, and Pharmacovigilance. These services work together to provide sponsors with end-to-end clinical trial support from Phase I-IV, with TrialKit serving as the underlying EDC technology enabling data collection across the service offerings.
Differentiator
Problem solved
Functional benefit
Products and services
- Biostatistics-PK/PD Analysis
- Statistical Programming Services
- Full Data Management
- End to End Clinical Operations
- Medical Writing
- Pharmacovigilance
Quantifiable outcome
- 95% customer retention rate over a decade of experience working on 170+ trials
- +2 more outcomes
Companies that use NoyMed
Customer profileNamed customers4 records
Segments4 records
Ideal customer profiles1 record
NoyMed technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
NoyMed partnerships and signals
Strategic signalScale indicators5 records
Recent moves6 records
Expansion highlights5 records
NoyMed competitors and assessment
Company assessmentDirect peers
- Medpace: Mid-size global CRO with strong biometrics and clinical operations capabilities serving biotech and pharma sponsors. Comparable in positioning as a science-focused mid-market CRO, though materially larger and publicly traded; relevant as a benchmark for NoyMed's potential scale-up trajectory.
- Worldwide Clinical Trials: Mid-tier global CRO offering biometrics, clinical operations, and pharmacovigilance to pharma and biotech. Comparable size and service mix to NoyMed, particularly in biometrics-heavy Phase II/III work.
- PSI CRO: Privately held global CRO with strong biometrics, data management, and full-service clinical operations. Comparable mid-tier private CRO profile and multi-geography delivery model.
- Synteract: Mid-sized CRO (now part of Syneos) offering biometrics, data management, and full-service clinical trial support to biotech and pharma. Similar size, service breadth, and sponsor mix to NoyMed.
- Premier Research: Mid-sized CRO with deep biometrics, clinical operations, and medical writing capabilities focused on biotech and specialty pharma. Directly comparable in scale, therapeutic breadth, and biometrics-led positioning.
Broad incumbents
- Parexel: Large global CRO offering full-service clinical trial, biometrics, and pharmacovigilance solutions to pharma and biotech. Comparable service overlap, though at significantly larger scale and with broader geographic coverage.
- ICON plc: One of the world's largest CROs offering full-service clinical, biometrics, and pharmacovigilance capabilities globally. Represents the tier of incumbents NoyMed competes against for large enterprise deals.
- IQVIA: Largest global CRO/biopharma services firm with end-to-end biometrics, clinical operations, and real-world evidence capabilities. Relevant as the dominant incumbent setting industry benchmarks and pricing.
- Charles River Laboratories: Large life-sciences services firm with significant CRO and biometrics offerings. Comparable service categories (biostatistics, data management, pharmacovigilance) but operates at vastly greater scale.
Emerging players
- Novotech: Asia-Pacific-headquartered CRO with growing global biometrics and clinical operations footprint. Comparable as a mid-sized, growth-oriented CRO competing for biotech sponsors, with similar cost-arbitrage delivery model.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks7 records
Key highlights7 records
Customer concentration
NoyMed social profiles
Digital presenceNoyMed financial estimates
Financial estimateRevenue estimate
Valuation estimate
NoyMed leadership team
Management profileNumber of profiles
Profiles3 records
NoyMed funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
NoyMed M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about NoyMed
What does NoyMed do?
NoyMed is a Contract Research Organization (CRO) providing biometrics and clinical operations services to pharmaceutical, biotechnology, and medical device companies. Its services include biostatistics and PK/PD analysis, SAS statistical programming with CDISC-compliant datasets, full data management on the TrialKit EDC platform, end-to-end clinical trial operations, medical writing, and pharmacovigilance.
Is NoyMed a public or private company?
NoyMed is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was NoyMed founded?
NoyMed was founded in 2017. It employs 101 to 250 people.
Where is NoyMed based?
NoyMed is headquartered in Glendale, United States, in the North America region.
How does NoyMed make money?
One revenue line is on record: clinical Research Services.
Who are NoyMed's main competitors?
Direct peers on record are Medpace, Worldwide Clinical Trials, PSI CRO, Synteract and Premier Research. Broad incumbents are Parexel, ICON plc, IQVIA and Charles River Laboratories. Novotech is listed as an emerging player.
Does NoyMed have an API?
No public API is recorded for NoyMed.
What industry is NoyMed in?
NoyMed's product category is Contract Research Organization (CRO) Services. Its primary akta.pro industry code is HLAGAAAF, Clinical Data Management, Biostatistics & Statistical Programming CROs, with a secondary code of HLAGAAAE, Central Laboratory & Clinical Trial Testing CROs. Its NAICS code is 5417 and its SIC code is 8731.